iRadimed (IRMD)
(Delayed Data from NSDQ)
$50.41 USD
+1.32 (2.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $50.40 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Brokerage Reports
0 items in cart
iRadimed Corporation [IRMD]
Reports for Purchase
Showing records 1 - 20 ( 174 total )
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
We reiterate our Buy rating and increase our target price to $61 from $58.
Provider: Singular Research
Analyst: DILORENZO F
Company: iRadimed Corporation
Industry: Medical - Instruments
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: iRadimed Corporation
Industry: Medical - Instruments
Optimized Entry and Exit Levels for IRMD 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
2Q23 Recap - Catalysts Forming for 2024 and 2025
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
1Q23 Recap - Strong Momentum Continues; PT to $50
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S